New legislation, key court cases, and trends affecting patents, marketing, privacy, product liability, and more.
January 1, 2013
Courts across the country are making it easier to prove that a drug is unsafe, warning label notwithstanding.
|
|
October 1, 2012
With the costs of data storage poised to increase, pharmaceutical companies need to break their pack rat mentality with respect to data, writes Lorrie Luellig.
|
March 1, 2012
Pharmaceutical trade dres is an effective marketing tool that helps boost product recognition for consumers. It's worth protecting.
|
|
February 1, 2012
By:
John Shaeffer, Brianna Dahlberg
State tech transfer laws giving universities automatic ownership of employees' inventions represent a threat to pharma partnerships—but the Supreme Court is poised to intervene in the industry's favor.
|
|
January 1, 2012
By:
Jennifer Ringler
Pharma must coordinate the efforts of medical, legal, HR, global partners and many other players in the regulatory compliance space to keep itself afloat in choppy seas.
|
July 1, 2011
By:
Todd C. Davis
Structuring a good deal depends on understanding your partner—and a high degree of specificity
|
May 1, 2011
By:
John Brenner
To what extent are generics companies obligated by law to request labeling changes with FDA?
|
|
March 1, 2011
The Federal Circuit court continues its trend in tightening the standards for establishing patent damages by leapfrogging a stalled legislative process
|
|
PharmExec Blog
Follow Us
RSS
Bookstore
